IntrinsicIntrinsic
← Scroll for more →

Usana Health Sciences Inc (USNA)

Medicinal Chemicals & Botanical Products

Latest Price
$14.07
TTM P/E
--
Normalized P/E
6.71
TTM Div Yield
--
Fwd Div Yield
--
Book Value
28.49
P/B Ratio
0.49

Valuation metrics

adjust assumptions →
EPS: $0.58
Book value / share: $29.16
Formula: √(22.5 × EPS × BVPS)
Graham Number
$19.51
+39% upside
Norm. op. income: $108M (median of 5yr)
Tax rate: 36%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$46.25
+229% upside
Base FCF: $94M (median of recent 5yr)
Growth: -15%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$30.45
+116% upside
EPS: $0.58
Target P/E: 7×
Formula: EPS × P/E
P/E Fair Value
$4.06
71% downside

Institutional Ownership

62.3% held by institutions
InstitutionSharesValueOwnership %ChangeFiling Date
BlackRock, Inc.1.55M$33.0M8.42%+363.8K2026-06-30
Pzena Investment Management LLC1.21M$25.0M6.53%+96.7K2026-06-30
Renaissance Technologies LLC958.5K$20.0M5.19%-59.1K2026-06-30
Dimensional Fund Advisors LP837.4K$17.0M4.54%+3.2K2026-06-30
Nantahala Capital Management, LLC810.1K$17.0M4.39%--2026-06-30
Vanguard Capital Management LLC487.4K$10.0M2.64%+8.3K2026-06-30
Creative Planning418.0K$8.0M2.26%+224.8K2026-06-30
AQR Capital Management LLC408.1K$8.0M2.21%+111.7K2026-06-30
Vanguard Portfolio Management LLC363.4K$7.0M1.97%+25.1K2026-06-30
Geode Capital Management, LLC283.2K$6.0M1.53%+18.7K2026-06-30
View all institutional holders →